Cargando…
Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
Imaging protein kinase expression with radiolabeled small molecule inhibitors has been actively pursued to monitor the clinical potential of targeted therapeutics and treatments as well as to determine kinase receptor density changes related to disease progression. The goal of the present review is...
Autores principales: | Hicks, Justin W., VanBrocklin, Henry F., Wilson, Alan A., Houle, Sylvain, Vasdev, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259110/ https://www.ncbi.nlm.nih.gov/pubmed/21079565 http://dx.doi.org/10.3390/molecules15118260 |
Ejemplares similares
-
Radiolabelling of Extracellular Vesicles for PET and SPECT imaging
por: Khan, Azalea A., et al.
Publicado: (2021) -
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2015) -
Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
por: Kanagasundaram, Thines, et al.
Publicado: (2021) -
Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging
por: Gawne, Peter J., et al.
Publicado: (2022) -
PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)